| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| EXELExelixis, Inc. | 11.81B | 44.06 | 15.85 | 6.98% | 29.63% | 31.37% | 7.49% | 0.08 |
| INCYIncyte Corporation | 20.1B | 101.27 | 15.80 | 21.22% | 25.03% | 24.9% | 6.74% | 0.01 |
| GMABGenmab A/S | 18.13B | 29.44 | 15.36 | 30.67% | 46.8% | 114.25% | 6.6% | 0.03 |
| SNDXSyndax Pharmaceuticals, Inc. | 1.89B | 21.71 | -5.82 | -279.31% | -269.93% | 1.20 | ||
| RCUSArcus Biosciences, Inc. | 2.55B | 20.37 | -6.19 | -4.26% | -142.91% | -55.94% | 0.16 | |
| RLAYRelay Therapeutics, Inc. | 1.78B | 10.26 | -6.37 | 53.44% | -18.01% | -48.76% | 0.06 | |
| STROSutro Biopharma, Inc. | 1.74B | 20.47 | -6.92 | -59.64% | -205.18% | -234.19% | 4.57 | |
| OLMAOlema Pharmaceuticals, Inc. | 1.66B | 24.20 | -11 | -48.77% | 0.00 |
Analyze head-to-head performance against top industry competitors across valuation, growth, and profitability metrics.
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 236K | 44K | 45K | 47K | 43K | 605K | 934K | 240K | 622K | 14.74M |
| Revenue Growth % | -63.18% | -81.36% | 2.27% | 4.44% | -8.51% | 1306.98% | 54.38% | -74.3% | 159.17% | 2270.58% |
| Cost of Goods Sold | 0 | 0 | 0 | -3.11M | 9.01M | 0 | 0 | 0 | 0 | 0 |
| COGS % of Revenue | - | - | - | -6617.02% | 20958.14% | - | - | - | - | - |
| Gross Profit | 236K | 44K | 45K | 3.16M | -8.97M | 605K | 934K | 240K | 622K | 14.74M |
| Gross Margin % | 100% | 100% | 100% | 6717.02% | -20858.14% | 100% | 100% | 100% | 100% | 100% |
| Gross Profit Growth % | -63.18% | -81.36% | 2.27% | 6915.56% | -384.1% | 106.75% | 54.38% | -74.3% | 159.17% | 2270.58% |
| Operating Expenses | 237.64M | 120.94M | 93.6M | 88.88M | 57.94M | 221.49M | 331.21M | 351.54M | 362.87M | 358.93M |
| OpEx % of Revenue | 100694.92% | 274856.82% | 207997.78% | 189108.51% | 134739.53% | 36609.09% | 35461.88% | 146474.17% | 58339.55% | 2434.23% |
| Selling, General & Admin | 226.21M | 94.39M | 53.82M | 35.46M | 9.05M | 71.32M | 135.26M | 102.71M | 129.62M | 168.78M |
| SG&A % of Revenue | 95850% | 214525% | 119602.22% | 75453.19% | 21053.49% | 11788.1% | 14481.37% | 42795% | 20839.23% | 1144.68% |
| Research & Development | 11.43M | 26.55M | 39.78M | 53.42M | 48.88M | 139.51M | 195.96M | 248.15M | 232.37M | 190.14M |
| R&D % of Revenue | 4844.92% | 60331.82% | 88395.56% | 113655.32% | 113686.05% | 23059.01% | 20980.51% | 103395.42% | 37357.88% | 1289.55% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 10.66M | 0 | 681K | 886K | 0 |
| Operating Income | -238.88M | -124.5M | -99.12M | -98.39M | -66.91M | -220.88M | -330.28M | -351.3M | -362.25M | -344.18M |
| Operating Margin % | -101218.64% | -282954.55% | -220266.67% | -209338.3% | -155597.67% | -36509.09% | -35361.88% | -146374.17% | -58239.55% | -2334.23% |
| Operating Income Growth % | -3745.4% | 47.88% | 20.39% | 0.74% | 32% | -230.13% | -49.53% | -6.36% | -3.12% | 4.99% |
| EBITDA | -237.4M | -120.89M | -93.55M | -88.83M | -57.9M | -208.14M | -316.04M | -333.04M | -343.74M | -326.63M |
| EBITDA Margin % | -100594.92% | -274756.82% | -207897.78% | -189008.51% | -134639.53% | -34403.47% | -33837.47% | -138765.83% | -55263.34% | -2215.18% |
| EBITDA Growth % | -3802.1% | 49.08% | 22.61% | 5.05% | 34.83% | -259.51% | -51.84% | -5.38% | -3.21% | 4.98% |
| D&A (Non-Cash Add-back) | 1.47M | 3.61M | 5.57M | 9.55M | 9.01M | 12.74M | 14.24M | 18.26M | 18.51M | 17.55M |
| EBIT | -237.18M | -121.31M | -96.3M | -96.3M | -65.87M | -216.96M | -334.99M | -370.14M | -497.18M | -281.99M |
| Net Interest Income | 0 | 0 | 0 | 0 | -3.16M | -7.35M | -14.01M | -44.44M | -85.85M | -129.26M |
| Interest Income | 0 | 0 | 0 | 0 | 2.76M | 1.73M | 836K | 2.71M | 863K | 2.4M |
| Interest Expense | 0 | 66K | 618K | 433K | 5.92M | 9.07M | 14.85M | 47.15M | 86.72M | 131.66M |
| Other Income/Expense | 1.7M | 3.12M | 2.2M | 1.66M | 1.02M | -5.15M | -19.56M | -65.99M | -221.64M | -69.46M |
| Pretax Income | -237.18M | -121.38M | -96.92M | -96.73M | -65.89M | -226.03M | -349.84M | -417.29M | -583.89M | -413.64M |
| Pretax Margin % | -100498.73% | -275865.91% | -215368.89% | -205806.38% | -153223.25% | -37360.83% | -37456% | -173869.17% | -93873.31% | -2805.32% |
| Income Tax | -301K | -572K | -493K | -503K | -97K | -1.85M | 9K | 34K | -40K | 0 |
| Effective Tax Rate % | 99.87% | 99.53% | 99.49% | 99.48% | 99.85% | 98.15% | 99.13% | 99.83% | 99.88% | 99.98% |
| Net Income | -236.88M | -120.81M | -96.42M | -96.23M | -65.79M | -221.85M | -346.79M | -416.57M | -583.2M | -413.56M |
| Net Margin % | -100371.19% | -274565.91% | -214273.33% | -204736.17% | -152997.67% | -36669.59% | -37129.55% | -173569.58% | -93761.41% | -2804.77% |
| Net Income Growth % | -3712.59% | 49% | 20.19% | 0.2% | 31.63% | -237.22% | -56.32% | -20.12% | -40% | 29.09% |
| Net Income (Continuing) | -236.88M | -120.81M | -96.42M | -96.23M | -65.79M | -224.19M | -349.85M | -417.32M | -583.85M | -413.64M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | -12.32M | 0 | 1.32M | -1.74M | -2.49M | 1.05M | 969K |
| EPS (Diluted) | -0.73 | -0.37 | -0.30 | -0.30 | -0.42 | -0.59 | -0.89 | -1.04 | -1.15 | -0.62 |
| EPS Growth % | -3605.58% | 49.32% | 18.92% | 0% | -40% | -40.48% | -50.85% | -16.85% | -10.58% | 46.09% |
| EPS (Basic) | -0.73 | -0.37 | -0.30 | -0.30 | -0.42 | -0.59 | -0.89 | -1.04 | -1.15 | -0.59 |
| Diluted Shares Outstanding | 326.3M | 328.55M | 316.15M | 325.05M | 383.18M | 383.18M | 389.23M | 399.9M | 508.64M | 700.44M |
| Basic Shares Outstanding | 326.3M | 328.55M | 316.15M | 325.05M | 383.18M | 383.18M | 389.23M | 399.9M | 508.64M | 697.31M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - | - | - |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 297.54M | 205.15M | 132.46M | 88.77M | 55.76M | 111.71M | 334.35M | 140.58M | 294.08M | 184.59M |
| Cash & Short-Term Investments | 294.22M | 198.92M | 128.15M | 74.15M | 51.65M | 96.06M | 317.12M | 107.18M | 266.46M | 149.81M |
| Cash Only | 175.91M | 8.08M | 23.87M | 16.82M | 15.51M | 34.91M | 181.1M | 104.64M | 265.45M | 143.43M |
| Short-Term Investments | 118.31M | 190.84M | 104.28M | 57.33M | 36.14M | 61.15M | 136.01M | 2.54M | 1.01M | 6.38M |
| Accounts Receivable | 1.77M | 0 | 1.26M | 12.17M | 303K | 2M | 1.33M | 1.89M | 3.17M | 2.65M |
| Days Sales Outstanding | 2.74K | - | 10.2K | 94.5K | 2.57K | 1.21K | 520.93 | 2.87K | 1.86K | 65.67 |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 8.27M |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 0 | 662K | 880K | 42K | 24K | 0 | 2.96M | 2.9M | 5.21M | 1.3M |
| Total Non-Current Assets | 69.31M | 112.35M | 117.98M | 93.18M | 87.37M | 109.67M | 134.56M | 221.78M | 210.37M | 198.35M |
| Property, Plant & Equipment | 6.15M | 19.27M | 76.73M | 76.89M | 72.23M | 90.68M | 119.17M | 189.45M | 182.68M | 170.46M |
| Fixed Asset Turnover | 0.04x | 0.00x | 0.00x | 0.00x | 0.00x | 0.01x | 0.01x | 0.00x | 0.00x | 0.09x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 7.29M | 5.09M | 2.83M | 12.09M | 0 | 1.46M | 1.42M | 20M | 17.09M | 15.93M |
| Long-Term Investments | 55.13M | 87.75M | 38.28M | 14.38M | 10.93M | 11.4M | 7.6M | 840K | 891K | 0 |
| Other Non-Current Assets | 344K | 137K | 151K | -1.67M | 4.21M | 6.13M | 6.38M | 11.49M | 9.7M | 11.96M |
| Total Assets | 366.85M | 317.5M | 250.44M | 181.95M | 143.12M | 221.38M | 468.91M | 362.36M | 504.45M | 382.93M |
| Asset Turnover | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.00x | 0.04x |
| Asset Growth % | 503.09% | -13.45% | -21.12% | -27.35% | -21.34% | 54.68% | 111.81% | -22.72% | 39.21% | -24.09% |
| Total Current Liabilities | 6.15M | 12.55M | 20.87M | 27.26M | 11.56M | 68.13M | 369M | 500.86M | 58.28M | 54.94M |
| Accounts Payable | 2.08M | 4.04M | 5.87M | 2.79M | 1.75M | 11.51M | 11.42M | 21.02M | 9.2M | 6.72M |
| Days Payables Outstanding | - | - | - | -327.8 | 70.84 | - | - | - | - | - |
| Short-Term Debt | -228K | 534K | 618K | 965K | 3.96M | 0 | 299.24M | 431.9M | 0 | 0 |
| Deferred Revenue (Current) | 228K | 197K | 520K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 4.06M | 7.78M | 13.87M | 23.5M | 4.78M | 18M | 16.52M | 19.74M | 18.31M | 15.98M |
| Current Ratio | 48.40x | 16.34x | 6.35x | 3.26x | 4.82x | 1.64x | 0.91x | 0.28x | 5.05x | 3.36x |
| Quick Ratio | 48.40x | 16.34x | 6.35x | 3.26x | 4.82x | 1.64x | 0.91x | 0.28x | 5.05x | 3.21x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 4.71M | 11.53M | 10.73M | 8.68M | 10.88M | 271.74M | 343.83M | 311.31M | 1.03B | 816.12M |
| Long-Term Debt | 2.47M | 0 | 0 | 0 | 0 | 254.35M | 306.35M | 241.27M | 681.54M | 461.88M |
| Capital Lease Obligations | 2.47M | 7.68M | 6.65M | 5.95M | 10.88M | 16.18M | 37.07M | 47.95M | 39.94M | 34.82M |
| Deferred Tax Liabilities | 1.17M | 996K | 498K | 0 | 0 | 170K | 162K | 0 | 0 | 0 |
| Other Non-Current Liabilities | -1.4M | 2.67M | 3.41M | 2.74M | 0 | 1.03M | 249K | 22.09M | 310.63M | 319.42M |
| Total Liabilities | 10.85M | 24.08M | 31.6M | 35.94M | 22.44M | 339.87M | 712.82M | 812.18M | 1.09B | 871.06M |
| Total Debt | 2.47M | 8.21M | 7.27M | 6.91M | 14.85M | 275.55M | 645.66M | 723.77M | 726.72M | 504.17M |
| Net Debt | -173.44M | 127K | -16.6M | -9.91M | -660K | 240.63M | 464.56M | 619.13M | 461.27M | 360.74M |
| Debt / Equity | 0.01x | 0.03x | 0.03x | 0.05x | 0.12x | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | -1886.36x | -160.39x | -227.23x | -11.30x | -24.34x | -22.24x | -7.45x | -4.18x | -2.61x |
| Total Equity | 356M | 293.42M | 218.84M | 133.69M | 120.68M | -118.49M | -243.91M | -449.82M | -585.94M | -488.13M |
| Equity Growth % | 509.34% | -17.58% | -25.42% | -38.91% | -9.73% | -198.19% | -105.85% | -84.42% | -30.26% | 16.69% |
| Book Value per Share | 1.09 | 0.89 | 0.69 | 0.41 | 0.31 | -0.31 | -0.63 | -1.12 | -1.15 | -0.70 |
| Total Shareholders' Equity | 356M | 293.42M | 218.84M | 146.01M | 120.68M | -119.81M | -242.17M | -447.33M | -586.99M | -489.1M |
| Common Stock | 8K | 8K | 8K | 8K | 10K | 38K | 40K | 42K | 67K | 85K |
| Retained Earnings | -250.38M | -387.06M | -498.71M | -594.98M | -662.19M | -1.62B | -1.96B | -2.38B | -2.96B | -3.38B |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -192K | -284K | -381K | -267K | -105K | 122K | 4K | 183K | 10K | 1.2M |
| Minority Interest | 0 | 0 | 0 | -12.32M | 0 | 1.32M | -1.74M | -2.49M | 1.05M | 969K |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | -25.3M | -38.59M | -48.78M | -63.38M | -152.11M | -171.72M | -274.42M | -337.51M | -366.76M | -391.24M |
| Operating CF Margin % | -10722.46% | -87711.36% | -108400% | -134853.19% | -353741.86% | -28384.13% | -29381.05% | -140628.75% | -58964.15% | -2653.35% |
| Operating CF Growth % | -372.64% | -52.51% | -26.4% | -29.93% | -139.99% | -12.9% | -59.8% | -22.99% | -8.67% | -6.67% |
| Net Income | -236.88M | -120.81M | -96.42M | -96.23M | -160.16M | -224.19M | -346.79M | -416.57M | -583.85M | -413.64M |
| Depreciation & Amortization | 1.47M | 3.61M | 5.57M | 9.55M | 14.04M | 12.74M | 14.3M | 34.54M | 18.51M | 17.55M |
| Stock-Based Compensation | 211.22M | 73.85M | 37M | 2.04M | 3.42M | 2.19M | 57.18M | 40.18M | 49.16M | 34.43M |
| Deferred Taxes | -302K | -575K | -497K | -498K | -8K | -2.94M | 0 | 0 | 0 | 0 |
| Other Non-Cash Items | 212.36M | 81.67M | 50.33M | 44.55M | 6.23M | 24.11M | 16.29M | 20.34M | 145.44M | -10.15M |
| Working Capital Changes | 282K | 3.84M | 3.23M | -554K | -15.64M | 16.36M | -15.39M | -16M | 3.98M | -19.42M |
| Change in Receivables | 75K | -1.46M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.36M |
| Change in Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -8.27M |
| Change in Payables | 627K | 888K | 150K | -1.1M | 1.19M | 2.57M | 0 | 0 | -6.48M | -3.17M |
| Cash from Investing | -175.22M | -113.67M | 99.55M | 57.1M | 18.55M | -19.81M | -84.89M | 27.3M | -30.47M | -12.25M |
| Capital Expenditures | -2.24M | -6.56M | -34.81M | -13.1M | -4.29M | -1.67M | -33.56M | -78.16M | -30.58M | -6.89M |
| CapEx % of Revenue | 949.58% | 14909.09% | 77366.67% | 27876.6% | 9969.77% | 275.87% | 3593.47% | 32567.5% | 4917.04% | 46.71% |
| Acquisitions | -1.82M | -137K | -32K | 412K | 200K | 8K | 0 | 0 | 0 | -1M |
| Investments | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -1.82M | 137K | 32K | 35.03M | -2.5M | -8K | -51.32M | 105.46M | 0 | -747K |
| Cash from Financing | 317.33M | -15.56M | -34.98M | -771K | 114.28M | 150.68M | 505.44M | 233.61M | 558.34M | 281.63M |
| Debt Issued (Net) | -132K | -32K | -19.93M | -477K | 47.67M | 63.7M | 338.5M | 174.07M | 258.62M | 96.89M |
| Equity Issued (Net) | 1000K | -1000K | -1000K | -171K | 1000K | 1000K | -1000K | -616K | 1000K | 1000K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | -4.8M | -15.85M | -15.23M | -228K | -2.5M | 0 | -4.06M | -616K | 0 | 0 |
| Other Financing | -2.42M | -1.11M | -1.04M | -123K | 39.11M | 673K | 171.01M | 60.16M | 189.62M | 73.38M |
| Net Change in Cash | 116.8M | -167.82M | 15.79M | -7.05M | -19.3M | -40.89M | 146.19M | -76.31M | 160.82M | -121.88M |
| Free Cash Flow | -27.55M | -45.15M | -83.59M | -76.48M | -156.4M | -173.39M | -307.98M | -415.67M | -397.34M | -398.12M |
| FCF Margin % | -11672.03% | -102620.45% | -185766.67% | -162729.79% | -363711.63% | -28660% | -32974.52% | -173196.25% | -63881.19% | -2700.06% |
| FCF Growth % | -387.28% | -63.92% | -85.14% | 8.51% | -104.48% | -10.87% | -77.62% | -34.97% | 4.41% | -0.2% |
| FCF per Share | -0.08 | -0.14 | -0.26 | -0.24 | -0.41 | -0.45 | -0.79 | -1.04 | -0.78 | -0.57 |
| FCF Conversion (FCF/Net Income) | 0.11x | 0.32x | 0.51x | 0.66x | 2.31x | 0.77x | 0.79x | 0.81x | 0.63x | 0.95x |
| Interest Paid | 0 | 0 | 0 | 0 | 19K | 40K | 2.11M | 35.44M | 77.19M | 92.32M |
| Taxes Paid | 0 | 0 | 0 | 0 | 3K | 8K | 0 | 0 | 8K | 15K |
| Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | -114.32% | -37.21% | -37.65% | -54.59% | -51.73% | -20269.62% | - | - | - | - |
| Return on Invested Capital (ROIC) | -196.73% | -39.23% | -29.99% | -45.27% | -41.17% | -136.82% | -144.53% | -135.13% | -1217.1% | - |
| Gross Margin | 100% | 100% | 100% | 6717.02% | -20858.14% | 100% | 100% | 100% | 100% | 100% |
| Net Margin | -100371.19% | -274565.91% | -214273.33% | -204736.17% | -152997.67% | -36669.59% | -37129.55% | -173569.58% | -93761.41% | -2804.77% |
| Debt / Equity | 0.01x | 0.03x | 0.03x | 0.05x | 0.12x | - | - | - | - | - |
| Interest Coverage | - | -1886.36x | -160.39x | -227.23x | -11.30x | -24.34x | -22.24x | -7.45x | -4.18x | -2.61x |
| FCF Conversion | 0.11x | 0.32x | 0.51x | 0.66x | 2.31x | 0.77x | 0.79x | 0.81x | 0.63x | 0.95x |
| Revenue Growth | -63.18% | -81.36% | 2.27% | 4.44% | -8.51% | 1306.98% | 54.38% | -74.3% | 159.17% | 2270.58% |
Explore detailed financial history, valuation models, and returns analysis
DCF models, peer multiples & analyst estimates
Historical returns with dividends reinvested
Yield, growth, payout safety & DRIP calculator
EPS trends, net income & profitability analysis
Long-term charts & historical price data
Sales growth patterns & revenue breakdown
30 years of valuation, profitability & efficiency metrics